Skip to contentB
Biogen Inc.
B
BIIBBiogen Inc. Source filing unavailable
Q2 2011 · —
Revenue$1.21B$1.21B−0.3% vs Q2 2010 Net Income$288.00M$288.00M−1.8% vs Q2 2010 EPS Diluted$1.18$1.18+5.4% vs Q2 2010 Gross Profit$1,108,100,000+0.2% Operating Income$410,813,000+3.8% Operating Cash Flowderived
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR
$429,666,000
+0.3%
Free Cash Flowderived$375,580,000−1.5% Margins · derivedGross margin91.7%+0.5 pt vs Q2 2010
Operating margin34.0%+1.3 pt vs Q2 2010
Net margin23.8%−0.4 pt vs Q2 2010